1. Home
  2. HLNE vs BLCO Comparison

HLNE vs BLCO Comparison

Compare HLNE & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hamilton Lane Incorporated

HLNE

Hamilton Lane Incorporated

HOLD

Current Price

$153.24

Market Cap

6.7B

Sector

Finance

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$17.28

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLNE
BLCO
Founded
1991
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Investment Managers
Ophthalmic Goods
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
6.0B
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
HLNE
BLCO
Price
$153.24
$17.28
Analyst Decision
Buy
Hold
Analyst Count
9
14
Target Price
$164.33
$17.31
AVG Volume (30 Days)
504.7K
332.5K
Earning Date
02-03-2026
02-18-2026
Dividend Yield
1.41%
N/A
EPS Growth
19.80
N/A
EPS
5.55
N/A
Revenue
$733,070,000.00
$4,976,000,000.00
Revenue This Year
$8.51
$8.06
Revenue Next Year
$20.20
$5.79
P/E Ratio
$27.55
N/A
Revenue Growth
13.01
6.23
52 Week Low
$111.98
$10.45
52 Week High
$179.19
$18.14

Technical Indicators

Market Signals
Indicator
HLNE
BLCO
Relative Strength Index (RSI) 70.43 56.07
Support Level $143.70 $17.18
Resistance Level $151.55 $17.86
Average True Range (ATR) 4.61 0.42
MACD 0.80 -0.02
Stochastic Oscillator 89.16 64.63

Price Performance

Historical Comparison
HLNE
BLCO

About HLNE Hamilton Lane Incorporated

Hamilton Lane Inc is a private markets investment firm globally, providing solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 750 professionals operating in offices throughout North America, Europe, Asia Pacific, and the Middle East. It has approximately $986 billion in assets under management and supervision, composed of nearly $141 billion in discretionary assets and more than $845 billion in non-discretionary assets. The group specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors, and geographies.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: